Combination prevention for COVID-19

Science. 2020 May 8;368(6491):551. doi: 10.1126/science.abc5798.

Authors

Myron S Cohen¹, Lawrence Corey²

Affiliations

¹ Myron S. Cohen is a professor in the Department of Medicine, Division of Infectious Diseases, and The Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. mscohen@med.unc.edu.
² Lawrence Corey is a professor in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center, Seattle, WA, and a Professor of Laboratory Medicine and Medicine at the University of Washington, Seattle, WA, USA. lcorey@fredhutch.org.

PMID: 32381692
DOI: 10.1126/science.abc5798

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antiviral Agents / therapeutic use
Behavior
Betacoronavirus* / immunology
COVID-19
COVID-19 Drug Treatment
COVID-19 Testing
COVID-19 Vaccines
Clinical Laboratory Techniques
Clinical Trials as Topic
Communicable Disease Control
Coronavirus Infections / diagnosis
Coronavirus Infections / drug therapy
Coronavirus Infections / prevention & control*
Coronavirus Infections / transmission
HIV Infections / drug therapy
HIV Infections / prevention & control
HIV Infections / transmission
Humans
Pandemics / prevention & control*
Pneumonia, Viral / diagnosis
Pneumonia, Viral / drug therapy
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / transmission
SARS-CoV-2
Viral Vaccines

Substances

Antibodies, Monoclonal
Antiviral Agents
COVID-19 Vaccines
Viral Vaccines